{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:53:19Z","timestamp":1789095199258,"version":"build-2803163510"},"reference-count":117,"publisher":"Oxford University Press (OUP)","issue":"Supplement_3","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100020166","name":"Flu Lab","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54EB027690"],"award-info":[{"award-number":["U54EB027690"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Point-of-care (POC) antigen-based diagnostics for influenza that have been granted waived status since the Clinical Laboratory Improvement Amendments of 1988 (CLIA-waived) have been available commercially in the United States for the last 25 years. Improved sensitivity, molecular, CLIA-waived tests have entered the market in the last 10 years. More recently, a new generation of assay technologies authorized for home use and available for over-the-counter sale has been introduced primarily though Emergency Use Authorization pathways during the SARS-CoV-2 pandemic. While evidence for the clinical impact of waived and home use diagnostic technologies is limited, their emerging availability and capabilities carry promise for impact on influenza management. In this review, we discuss the regulatory aspects, history, and capabilities of POC and home use influenza diagnostics. We draw on specific examples from the COVID-19 pandemic to propose ways in which these technologies can advance diagnostic and therapeutic strategies and highlight areas of need for ongoing investigation.<\/jats:p>","DOI":"10.1093\/infdis\/jiaf218","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T02:27:02Z","timestamp":1760668022000},"page":"S314-S326","source":"Crossref","is-referenced-by-count":13,"title":["Point-of-care and Home Use Influenza Diagnostics for Advancing Therapeutic and Public Health Strategies"],"prefix":"10.1093","volume":"232","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2237-1713","authenticated-orcid":false,"given":"Gregory L","family":"Damhorst","sequence":"first","affiliation":[{"name":"Center for the Advancement of Diagnostics for a Just Society, Emory University , Atlanta, Georgia ,","place":["USA"]},{"name":"Atlanta Center for Microsystems Engineered Point-of-Care Technologies , Atlanta, Georgia ,","place":["USA"]},{"name":"Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0325-7990","authenticated-orcid":false,"given":"Wilbur A","family":"Lam","sequence":"additional","affiliation":[{"name":"Center for the Advancement of Diagnostics for a Just Society, Emory University , Atlanta, Georgia ,","place":["USA"]},{"name":"Atlanta Center for Microsystems Engineered Point-of-Care Technologies , Atlanta, Georgia ,","place":["USA"]},{"name":"Department of Pediatrics, Division of Pediatric Hematology\/Oncology, Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta, Emory University School of Medicine , Atlanta, Georgia ,","place":["USA"]},{"name":"Wallace H. Coulter Department of Biomedical Engineering, Emory University and Georgia Institute of Technology , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"2025101622264892000_jiaf218-B1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciy866","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza A","volume":"68","author":"Uyeki","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2025101622264892000_jiaf218-B2","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMc2405371","article-title":"Highly pathogenic avian influenza A(H5N1) virus infection in a dairy farm worker","volume":"390","author":"Uyeki","year":"2024","journal-title":"N Engl J Med"},{"key":"2025101622264892000_jiaf218-B3","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMc2405937","article-title":"Sequencing-based detection of avian influenza A(H5N1) virus in wastewater in ten cities","volume":"391","author":"Tisza","year":"2024","journal-title":"N Engl J Med"},{"key":"2025101622264892000_jiaf218-B4","doi-asserted-by":"crossref","first-page":"105723","DOI":"10.1016\/j.jcv.2024.105723","article-title":"Opportunities and challenges for the U.S. Laboratory response to highly pathogenic avian influenza A(H5N1)","volume":"174","author":"Pinsky","year":"2024","journal-title":"J Clin Virol"},{"key":"2025101622264892000_jiaf218-B5","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1056\/NEJMc2407264","article-title":"Influenza A(H5N1) virus infection in two dairy farm workers in Michigan","volume":"391","author":"Morse","year":"2024","journal-title":"N Engl J Med"},{"key":"2025101622264892000_jiaf218-B6","author":"US Food and Drug Administration"},{"key":"2025101622264892000_jiaf218-B7","author":"US Food and Drug Administration"},{"key":"2025101622264892000_jiaf218-B8","author":"US Food and Drug Administration"},{"key":"2025101622264892000_jiaf218-B9","author":"US Food and Drug Administration"},{"key":"2025101622264892000_jiaf218-B10","author":"US Food and Drug Administration"},{"key":"2025101622264892000_jiaf218-B11","author":"US Food and Drug Administration"},{"key":"2025101622264892000_jiaf218-B12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1042\/EBC20150012","article-title":"Lateral flow assays","volume":"60","author":"Koczula","year":"2016","journal-title":"Essays Biochem"},{"key":"2025101622264892000_jiaf218-B13","doi-asserted-by":"crossref","first-page":"E63","DOI":"10.1093\/nar\/28.12.e63","article-title":"Loop-mediated isothermal amplification of DNA","volume":"28","author":"Notomi","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"2025101622264892000_jiaf218-B14","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1073\/pnas.0730811100","article-title":"Isothermal reactions for the amplification of oligonucleotides","volume":"100","author":"Van Ness","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025101622264892000_jiaf218-B15","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1039\/D0AN01988G","article-title":"Current state of commercial point-of-care nucleic acid tests for infectious diseases","volume":"146","author":"Zhang","year":"2021","journal-title":"Analyst"},{"key":"2025101622264892000_jiaf218-B16","author":"US Food and Drug Administration"},{"key":"2025101622264892000_jiaf218-B17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jcv.2019.05.002","article-title":"CLIA-waived molecular influenza testing in the emergency department and outpatient settings","volume":"116","author":"Babady","year":"2019","journal-title":"J Clin Virol"},{"key":"2025101622264892000_jiaf218-B18","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00367-18","article-title":"Detection of influenza A and B viruses and respiratory syncytial virus by use of clinical laboratory improvement amendments of 1988 (CLIA)-waived point-of-care assays: a paradigm shift to molecular tests","volume":"56","author":"Azar","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2025101622264892000_jiaf218-B19","author":"Abbott"},{"key":"2025101622264892000_jiaf218-B20","author":"BD"},{"key":"2025101622264892000_jiaf218-B21","author":"Sekisui"},{"key":"2025101622264892000_jiaf218-B22","author":"Sekisui"},{"key":"2025101622264892000_jiaf218-B23","author":"Quidel"},{"key":"2025101622264892000_jiaf218-B24","author":"Quidel"},{"key":"2025101622264892000_jiaf218-B25"},{"key":"2025101622264892000_jiaf218-B26","author":"Abbott"},{"key":"2025101622264892000_jiaf218-B27","author":"BIOM\u00c9RIEUX"},{"key":"2025101622264892000_jiaf218-B28","author":"BIOM\u00c9RIEUX"},{"key":"2025101622264892000_jiaf218-B29","author":"Cepheid"},{"key":"2025101622264892000_jiaf218-B30","author":"Cepheid"},{"key":"2025101622264892000_jiaf218-B31","author":"Thermo Fisher Scientific"},{"key":"2025101622264892000_jiaf218-B32","author":"Roche"},{"key":"2025101622264892000_jiaf218-B33","author":"Roche"},{"key":"2025101622264892000_jiaf218-B34","author":"Roche"},{"key":"2025101622264892000_jiaf218-B35","author":"Nuclein"},{"key":"2025101622264892000_jiaf218-B36"},{"key":"2025101622264892000_jiaf218-B37","author":"US Food and Drug Administration"},{"key":"2025101622264892000_jiaf218-B38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12250-020-00230-5","article-title":"On the calculation of TCID50 for quantitation of virus infectivity","volume":"36","author":"Lei","year":"2021","journal-title":"Virol Sin"},{"key":"2025101622264892000_jiaf218-B39"},{"key":"2025101622264892000_jiaf218-B40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1373\/clinchem.2013.202655","article-title":"The long gestation of the modern home pregnancy test","volume":"60","author":"Braunstein","year":"2014","journal-title":"Clin Chem"},{"key":"2025101622264892000_jiaf218-B41","author":"National Institutes of Health"},{"key":"2025101622264892000_jiaf218-B42","author":"US Food and Drug Administration"},{"key":"2025101622264892000_jiaf218-B43","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMsr2022263","article-title":"Rapid scaling up of COVID-19 diagnostic testing in the United States\u2014the NIH RADx initiative","volume":"383","author":"Tromberg","year":"2020","journal-title":"N Engl J Med"},{"key":"2025101622264892000_jiaf218-B44","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/S2468-2667(24)00279-2","article-title":"The SARS-CoV-2 test scale-up in the USA: an analysis of the number of tests produced and used over time and their modelled impact on the COVID-19 pandemic","volume":"10","author":"Santos","year":"2025","journal-title":"Lancet Public Health"},{"key":"2025101622264892000_jiaf218-B45","author":"Acon"},{"key":"2025101622264892000_jiaf218-B46","author":"CorDx"},{"key":"2025101622264892000_jiaf218-B47","author":"iHealth"},{"key":"2025101622264892000_jiaf218-B48","author":"Osang Healthcare"},{"key":"2025101622264892000_jiaf218-B49","author":"Pfizer"},{"key":"2025101622264892000_jiaf218-B50","author":"Sekisui"},{"key":"2025101622264892000_jiaf218-B51","author":"Watmind USA"},{"key":"2025101622264892000_jiaf218-B52","author":"Wondfo"},{"key":"2025101622264892000_jiaf218-B53","author":"Healgen"},{"key":"2025101622264892000_jiaf218-B54","author":"US Food and Drug Administration"},{"key":"2025101622264892000_jiaf218-B55","author":"US Food and Drug Administration"},{"key":"2025101622264892000_jiaf218-B56","article-title":"First at-home combination test for flu and COVID is OK\u2019d by the F.D.A","author":"Anthes","year":"24  2023","journal-title":"The New York Times"},{"key":"2025101622264892000_jiaf218-B57","author":"US Food and Drug Administration"},{"key":"2025101622264892000_jiaf218-B58","author":"US Food and Drug Administration"},{"key":"2025101622264892000_jiaf218-B59","author":"Thermo Fisher Scientific"},{"key":"2025101622264892000_jiaf218-B60","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1039\/D2LC00081D","article-title":"Designing for simplicity: lessons from mesa biotech for microfluidic entrepreneurs and early-stage companies","volume":"22","author":"Greenleaf","year":"2022","journal-title":"Lab Chip"},{"key":"2025101622264892000_jiaf218-B61","author":"Yerak"},{"key":"2025101622264892000_jiaf218-B62","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/infdis\/jiae379","article-title":"An update on highly pathogenic avian influenza A(H5N1) virus, clade 2.3.4.4b","volume":"230","author":"Webby","year":"2024","journal-title":"J Infect Dis"},{"key":"2025101622264892000_jiaf218-B63","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJMp2406427","article-title":"D\u00e9j\u00e0 vu all over again\u2014refusing to learn the lessons of COVID-19","volume":"391","author":"Sinha","year":"2024","journal-title":"N Engl J Med"},{"key":"2025101622264892000_jiaf218-B64","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3201\/eid3007.240508","article-title":"Highly pathogenic avian influenza A(H5N1) clade 2.3.4.4b virus infection in domestic dairy cattle and cats, United States, 2024","volume":"30","author":"Burrough","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"2025101622264892000_jiaf218-B65","article-title":"Towards diagnostic preparedness: detection of highly pathogenic avian influenza A(H5N1) in contrived nasal swab specimens using rapid antigen and point-of-care molecular tests","author":"Bassit","journal-title":"medRxiv"},{"key":"2025101622264892000_jiaf218-B66","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/cid\/cix461","article-title":"Rapid tests for influenza, respiratory syncytial virus, and other respiratory viruses: a systematic review and meta-analysis","volume":"65","author":"Bruning","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2025101622264892000_jiaf218-B67","doi-asserted-by":"crossref","first-page":"394","DOI":"10.7326\/M17-0848","article-title":"Diagnostic accuracy of novel and traditional rapid tests for influenza infection compared with reverse transcriptase polymerase chain reaction: a systematic review and meta-analysis","volume":"167","author":"Merckx","year":"2017","journal-title":"Ann Intern Med"},{"key":"2025101622264892000_jiaf218-B68","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.cmi.2017.11.018","article-title":"Multiplex PCR system for the rapid diagnosis of respiratory virus infection: systematic review and meta-analysis","volume":"24","author":"Huang","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2025101622264892000_jiaf218-B69","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4046\/trd.2021.0033","article-title":"Diagnostic accuracy of the Quidel Sofia rapid influenza fluorescent immunoassay in patients with influenza-like illness: a systematic review and meta-analysis","volume":"84","author":"Lee","year":"2021","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"2025101622264892000_jiaf218-B70","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cmi.2021.09.025","article-title":"Diagnostic accuracy of point-of-care tests in acute community-acquired lower respiratory tract infections. A systematic review and meta-analysis","volume":"28","author":"Gentilotti","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2025101622264892000_jiaf218-B71","doi-asserted-by":"publisher","DOI":"10.3310\/JLCP4570","article-title":"Diagnostic accuracy of point-of-care tests for acute respiratory infection: a systematic review of reviews [published online ahead of print 2 October 2024]","author":"Webster","journal-title":"Health Technol Assess"},{"key":"2025101622264892000_jiaf218-B72","doi-asserted-by":"crossref","first-page":"102090","DOI":"10.1016\/j.japh.2024.102090","article-title":"Multiplex CLIA-waived point-of-care tests for SARS-CoV-2, influenza A and B, +\/- other respiratory pathogens: a systematic review","volume":"64","author":"Bernknopf","year":"2024","journal-title":"J Am Pharm Assoc (2003)"},{"key":"2025101622264892000_jiaf218-B73","doi-asserted-by":"crossref","first-page":"105706","DOI":"10.1016\/j.jcv.2024.105706","article-title":"Clinical performance of the Roche Cobas Liat SARS-CoV-2 & influenza A\/B assay: a systematic review and meta-analysis","volume":"174","author":"Chang","year":"2024","journal-title":"J Clin Virol"},{"key":"2025101622264892000_jiaf218-B74","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/14737159.2017.1372195","article-title":"The impact of commercial rapid respiratory virus diagnostic tests on patient outcomes and health system utilization","volume":"17","author":"Ko","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"key":"2025101622264892000_jiaf218-B75","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/cid\/ciy837","article-title":"The clinical utility of point-of-care tests for influenza in ambulatory care: a systematic review and meta-analysis","volume":"69","author":"Lee","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2025101622264892000_jiaf218-B76","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1001\/jamainternmed.2024.0037","article-title":"Clinical outcomes of rapid respiratory virus testing in emergency departments","volume":"184","author":"Schober","year":"2024","journal-title":"JAMA Intern Med"},{"key":"2025101622264892000_jiaf218-B77","doi-asserted-by":"crossref","first-page":"e1995","DOI":"10.1002\/rmv.1995","article-title":"Systematic review of the impact of point-of-care testing for influenza on the outcomes of patients with acute respiratory tract infection","volume":"28","author":"Egilmezer","year":"2018","journal-title":"Rev Med Virol"},{"key":"2025101622264892000_jiaf218-B78","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jinf.2023.03.005","article-title":"Rapid multiplex PCR for respiratory viruses reduces time to result and improves clinical care: results of a systematic review and meta-analysis","volume":"86","author":"Clark","year":"2023","journal-title":"J Infect"},{"key":"2025101622264892000_jiaf218-B79","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3390\/antibiotics11091192","article-title":"Point-of-care and rapid tests for the etiological diagnosis of respiratory tract infections in children: a systematic review and meta-analysis","volume":"11","author":"Brigadoi","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"2025101622264892000_jiaf218-B80","doi-asserted-by":"crossref","first-page":"ofad443","DOI":"10.1093\/ofid\/ofad443","article-title":"The effect of rapid point-of-care respiratory pathogen testing on antibiotic prescriptions in acute infections-A systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Kuitunen","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2025101622264892000_jiaf218-B81","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/labmed\/lmac154","article-title":"Increases in CLIA-waived testing sites since the start of the COVID-19 pandemic","volume":"54","author":"Xia","year":"2023","journal-title":"Lab Med"},{"key":"2025101622264892000_jiaf218-B82","doi-asserted-by":"crossref","first-page":"206","DOI":"10.15585\/mmwr.mm7208a2","article-title":"Effect of predeparture testing on postarrival SARS-CoV-2-positive test results among international travelers\u2014CDC traveler-based genomic surveillance program, four U.S. Airports, march-September 2022","volume":"72","author":"Bart","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025101622264892000_jiaf218-B83","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S1473-3099(21)00268-1","article-title":"Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trial","volume":"21","author":"Revollo","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2025101622264892000_jiaf218-B84","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1473-3099(21)00673-3","article-title":"Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trial","volume":"22","author":"Delaugerre","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2025101622264892000_jiaf218-B85","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.1093\/cid\/ciac440","article-title":"Utility of a test-to-return strategy to identify individuals with coronavirus disease 2019 (COVID-19) in the prekindergarten through grade 12 school setting-district of Columbia, January 2022","volume":"75","author":"Samson","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2025101622264892000_jiaf218-B86","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0140-6736(21)01908-5","article-title":"Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial","volume":"398","author":"Young","year":"2021","journal-title":"Lancet"},{"key":"2025101622264892000_jiaf218-B87","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S2352-4642(23)00312-7","article-title":"What is the specific role of schools and daycares in COVID-19 transmission? A final report from a living rapid review","volume":"8","author":"Neil-Sztramko","year":"2024","journal-title":"Lancet Child Adolesc Health"},{"key":"2025101622264892000_jiaf218-B88","first-page":"CD008965","article-title":"Neuraminidase inhibitors for preventing and treating influenza in adults and children","volume":"4","author":"Jefferson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2025101622264892000_jiaf218-B89","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0140-6736(14)62449-1","article-title":"Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials","volume":"385","author":"Dobson","year":"2015","journal-title":"Lancet"},{"key":"2025101622264892000_jiaf218-B90","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/jac\/dkg007","article-title":"Early administration of oral oseltamivir increases the benefits of influenza treatment","volume":"51","author":"Aoki","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"2025101622264892000_jiaf218-B91","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1473-3099(13)70267-6","article-title":"Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial","volume":"14","author":"Fry","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"2025101622264892000_jiaf218-B92","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/jac\/dkq409","article-title":"Is non-prescription oseltamivir availability under strict criteria workable? A qualitative study in New Zealand","volume":"66","author":"Gauld","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2025101622264892000_jiaf218-B93","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/jac\/dks337","article-title":"Five years of non-prescription oseltamivir: effects on resistance, immunization and stockpiling","volume":"67","author":"Gauld","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2025101622264892000_jiaf218-B94","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/ijpp.12200","article-title":"Barriers to positive policy change that aims to increase access to medicines through reclassification: the case of oseltamivir in New Zealand","volume":"24","author":"Shaw","year":"2016","journal-title":"Int J Pharm Pract"},{"key":"2025101622264892000_jiaf218-B95","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/phar.2370","article-title":"Oseltamivir for all: should it become an over-the-counter medication for influenza treatment?","volume":"40","author":"Rech","year":"2020","journal-title":"Pharmacotherapy"},{"key":"2025101622264892000_jiaf218-B96","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/cid\/civ733","article-title":"Impact of prompt influenza antiviral treatment on extended care needs after influenza hospitalization among community-dwelling older adults","volume":"61","author":"Chaves","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2025101622264892000_jiaf218-B97","doi-asserted-by":"crossref","first-page":"512","DOI":"10.7326\/0003-4819-156-7-201204030-00411","article-title":"Antivirals for treatment of influenza","volume":"156","author":"Hsu","year":"2012","journal-title":"Ann Internal Med"},{"key":"2025101622264892000_jiaf218-B98","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/infdis\/jiw033","article-title":"Benefit of early initiation of influenza antiviral treatment to pregnant women hospitalized with laboratory-confirmed influenza","volume":"214","author":"Oboho","year":"2016","journal-title":"J Infect Dis"},{"key":"2025101622264892000_jiaf218-B99","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1093\/infdis\/jiaf116","article-title":"Use of influenza antivirals to prevent transmission","volume":"232","author":"Cowling","year":"2025","journal-title":"J Infect Dis"},{"key":"2025101622264892000_jiaf218-B100","doi-asserted-by":"crossref","first-page":"S327","DOI":"10.1093\/infdis\/jiaf152","article-title":"Improving Access to Influenza Testing and Treatment: Is it Time for Over-the-Counter Oseltamivir?","volume":"232","author":"Lee","year":"2025","journal-title":"J Infect Dis"},{"key":"2025101622264892000_jiaf218-B101","doi-asserted-by":"crossref","first-page":"e2252684","DOI":"10.1001\/jamanetworkopen.2022.52684","article-title":"Unreported SARS-CoV-2 home testing and test positivity","volume":"6","author":"Park","year":"2023","journal-title":"JAMA Network Open"},{"key":"2025101622264892000_jiaf218-B102","author":"National Institute of Biomedical Imaging and Bioengineering"},{"key":"2025101622264892000_jiaf218-B103","author":"National Institutes of Health"},{"key":"2025101622264892000_jiaf218-B104","doi-asserted-by":"crossref","first-page":"e2322299","DOI":"10.1001\/jamanetworkopen.2023.22299","article-title":"Use of natural language processing of patient-initiated electronic health record messages to identify patients with COVID-19 infection","volume":"6","author":"Mermin-Bunnell","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2025101622264892000_jiaf218-B105","author":"Centers for Disease Control and Prevention"},{"key":"2025101622264892000_jiaf218-B106","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3201\/eid2206.151080","article-title":"Heterogeneous and dynamic prevalence of asymptomatic influenza virus infections","volume":"22","author":"Furuya-Kanamori","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"2025101622264892000_jiaf218-B107","doi-asserted-by":"crossref","first-page":"04063","DOI":"10.7189\/jogh.13.04063","article-title":"The prevalence of influenza bacterial co-infection and its role in disease severity: a systematic review and meta-analysis","volume":"13","author":"Qiao","year":"2023","journal-title":"J Glob Health"},{"key":"2025101622264892000_jiaf218-B108","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/infdis\/jiab107","article-title":"Persistent SARS-CoV-2 RNA shedding without evidence of infectiousness: a cohort study of individuals with COVID-19","volume":"224","author":"Owusu","year":"2021","journal-title":"J Infect Dis"},{"key":"2025101622264892000_jiaf218-B109","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.15585\/mmwr.mm695152a3","article-title":"Performance of an antigen-based test for asymptomatic and symptomatic SARS-CoV-2 testing at two university campuses\u2014Wisconsin, September-October 2020","volume":"69","author":"Pray","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025101622264892000_jiaf218-B110","doi-asserted-by":"crossref","first-page":"100","DOI":"10.15585\/mmwr.mm7003e3","article-title":"Evaluation of Abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection at two community-based testing sites\u2014Pima county, Arizona, November 3\u201317, 2020","volume":"70","author":"Prince-Guerra","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025101622264892000_jiaf218-B111","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jiac.2021.05.006","article-title":"Does the SARS-CoV-2 rapid antigen test result correlate with the viral culture result?","volume":"27","author":"Yamamoto","year":"2021","journal-title":"J Infect Chemother"},{"key":"2025101622264892000_jiaf218-B112","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3201\/eid2803.211747","article-title":"Relationship of SARS-CoV-2 antigen and reverse transcription PCR positivity for viral cultures","volume":"28","author":"Currie","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"2025101622264892000_jiaf218-B113","doi-asserted-by":"crossref","first-page":"e066871","DOI":"10.1136\/bmj-2021-066871","article-title":"SARS-CoV-2 antigen lateral flow tests for detecting infectious people: linked data analysis","volume":"376","author":"Deeks","year":"2022","journal-title":"BMJ"},{"key":"2025101622264892000_jiaf218-B114","doi-asserted-by":"crossref","first-page":"100222","DOI":"10.1016\/j.crmeth.2022.100222","article-title":"Don't forget about human factors: lessons learned from COVID-19 point-of-care testing","volume":"2","author":"Farmer","year":"2022","journal-title":"Cell Rep Methods"},{"key":"2025101622264892000_jiaf218-B115","author":"Centers for Medicare and Medicaid"},{"key":"2025101622264892000_jiaf218-B116","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s41512-018-0031-8","article-title":"Cost implications for the NHS of using the Alere\u2122 i influenza A & B near patient test with nasal swabs","volume":"2","author":"Allen","year":"2018","journal-title":"Diagn Progn Res"},{"key":"2025101622264892000_jiaf218-B117","doi-asserted-by":"crossref","first-page":"103840","DOI":"10.1016\/j.bjid.2024.103840","article-title":"Cost-consequence analysis of a combined COVID-19\/influenza rapid diagnostic test in the Brazilian private healthcare setting","volume":"28","author":"Lowin","year":"2024","journal-title":"Brazilian J Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/232\/Supplement_3\/S314\/64720105\/jiaf218.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/232\/Supplement_3\/S314\/64720105\/jiaf218.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T02:27:13Z","timestamp":1760668033000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/232\/Supplement_3\/S314\/8287902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":117,"journal-issue":{"issue":"Supplement_3","published-online":{"date-parts":[[2025,10,17]]},"published-print":{"date-parts":[[2025,10,17]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaf218","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10,15]]},"published":{"date-parts":[[2025,10,15]]}}}